Nexium Clinical Trials and Research Studies

Paid Clinical Trials and Focus Groups


Find Paid Clinical Trials

Paid Clinical Trials - : Nexium

Top of Directory » All Categories » by Drug Type » Nexium



  • Clopidogrel Proton-Pump Inhibitors Study

    Condition:   Coronary Artery Disease
    Interventions:   Drug: Omeprazole;   Drug: Pantoprazole
    Sponsor:   Sheba Medical Center
    Not yet recruiting - verified November 2009
  • Study Comparing Esomeprazole and ASA Combined Together as One Capsule Versus These Medications Taken Separately

    Condition:   Peptic Ulcer Disease
    Interventions:   Drug: Esomeprazole/ASA Fixed Combination;   Drug: Esomeprazole;   Drug: ASA
    Sponsor:   AstraZeneca
    Not yet recruiting - verified November 2009
  • Study to Compare Gastric Inhibition of Two Proton Pump Inhibitors (CL2008-18)

    Condition:   Human Experimentation
    Interventions:   Drug: Zegerid;   Drug: Prevacid;   Other: No Treatment
    Sponsor:   Schering-Plough
    Recruiting - verified October 2009
  • TMC278-TiDP6-C154: Evaluation of the Possible Influence of Omeprazole Intake - and the pH Increase in the Stomach Triggered by Omeprazole Intake - on the Blood Levels of TMC278 in Healthy Volunteers

    Condition:   HIV Infections
    Intervention:   Drug: TMC278; Omeprazole
    Sponsor:   Tibotec Pharmaceuticals, Ireland
    Not yet recruiting - verified November 2009
  • A Study to Evaluate the Effect of Famotidine and Omeprazole on MK0518 Pharmacokinetics in HIV-Infected Patients

    Conditions:   HIV-1 Infection;   HIV Infections
    Interventions:   Drug: MK0518;   Drug: famotidine;   Drug: omeprazole
    Sponsor:   Merck
    Completed - verified October 2009
  • Efficacy Study of Helicobacter Pylori Eradication in Patients Undergoing Subtotal Gastrectomy for Gastric Cancer

    Condition:   Gastric Cancer
    Interventions:   Drug: Helicobacter pylori eradication;   Drug: placebo
    Sponsor:   National Cancer Center, Korea
    Completed - verified October 2009
  • A Pharmacokinetic Study of RO5185426 in Combination With a Drug Cocktail in Patients With Metastatic Melanoma

    Condition:   Malignant Melanoma
    Interventions:   Drug: RO5185426;   Drug: Drug cocktail
    Sponsor:   Hoffmann-La Roche
    Not yet recruiting - verified October 2009
    • Menu
    Find Paid Clinical Trials